Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells

Abstract MR1-restricted T (MR1T) cells recognize microbial small molecule metabolites presented on the MHC Class I-like molecule MR1 and have been implicated in early effector responses to microbial infection. As a result, there is considerable interest in identifying chemical properties of metaboli...

Full description

Bibliographic Details
Main Authors: Haihong Jin, Nicole A. Ladd, Andrew M. Peev, Gwendolyn M. Swarbrick, Meghan Cansler, Megan Null, Christopher T. Boughter, Curtis McMurtrey, Aaron Nilsen, Karen M. Dobos, William H. Hildebrand, Deborah A. Lewinsohn, Erin J. Adams, David M. Lewinsohn, Melanie J. Harriff
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-26259-y
_version_ 1797973619391856640
author Haihong Jin
Nicole A. Ladd
Andrew M. Peev
Gwendolyn M. Swarbrick
Meghan Cansler
Megan Null
Christopher T. Boughter
Curtis McMurtrey
Aaron Nilsen
Karen M. Dobos
William H. Hildebrand
Deborah A. Lewinsohn
Erin J. Adams
David M. Lewinsohn
Melanie J. Harriff
author_facet Haihong Jin
Nicole A. Ladd
Andrew M. Peev
Gwendolyn M. Swarbrick
Meghan Cansler
Megan Null
Christopher T. Boughter
Curtis McMurtrey
Aaron Nilsen
Karen M. Dobos
William H. Hildebrand
Deborah A. Lewinsohn
Erin J. Adams
David M. Lewinsohn
Melanie J. Harriff
author_sort Haihong Jin
collection DOAJ
description Abstract MR1-restricted T (MR1T) cells recognize microbial small molecule metabolites presented on the MHC Class I-like molecule MR1 and have been implicated in early effector responses to microbial infection. As a result, there is considerable interest in identifying chemical properties of metabolite ligands that permit recognition by MR1T cells, for consideration in therapeutic or vaccine applications. Here, we made chemical modifications to known MR1 ligands to evaluate the effect on MR1T cell activation. Specifically, we modified 6,7-dimethyl-8-d-ribityllumazine (DMRL) to generate 6,7-dimethyl-8-d-ribityldeazalumazine (DZ), and then further derivatized DZ to determine the requirements for retaining MR1 surface stabilization and agonistic properties. Interestingly, the IFN-γ response toward DZ varied widely across a panel of T cell receptor (TCR)-diverse MR1T cell clones; while one clone was agnostic toward the modification, most displayed either an enhancement or depletion of IFN-γ production when compared with its response to DMRL. To gain insight into a putative mechanism behind this phenomenon, we used in silico molecular docking techniques for DMRL and its derivatives and performed molecular dynamics simulations of the complexes. In assessing the dynamics of each ligand in the MR1 pocket, we found that DMRL and DZ exhibit differential dynamics of both the ribityl moiety and the aromatic backbone, which may contribute to ligand recognition. Together, our results support an emerging hypothesis for flexibility in MR1:ligand-MR1T TCR interactions and enable further exploration of the relationship between MR1:ligand structures and MR1T cell recognition for downstream applications targeting MR1T cells.
first_indexed 2024-04-11T04:07:08Z
format Article
id doaj.art-2922d25154b844d9be6d978cad284414
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T04:07:08Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-2922d25154b844d9be6d978cad2844142023-01-01T12:18:11ZengNature PortfolioScientific Reports2045-23222022-12-0112111610.1038/s41598-022-26259-yDeaza-modification of MR1 ligands modulates recognition by MR1-restricted T cellsHaihong Jin0Nicole A. Ladd1Andrew M. Peev2Gwendolyn M. Swarbrick3Meghan Cansler4Megan Null5Christopher T. Boughter6Curtis McMurtrey7Aaron Nilsen8Karen M. Dobos9William H. Hildebrand10Deborah A. Lewinsohn11Erin J. Adams12David M. Lewinsohn13Melanie J. Harriff14Medicinal Chemistry Core, Oregon Health & Science UniversityDepartment of Biochemistry and Molecular Biology, University of ChicagoDepartment of Biochemistry and Molecular Biology, University of ChicagoDivision of Infectious Diseases, Department of Pediatrics, Oregon Health & Science UniversityDivision of Infectious Diseases, Department of Pediatrics, Oregon Health & Science UniversityDivision of Infectious Diseases, Department of Pediatrics, Oregon Health & Science UniversityGraduate Program in Biophysical Sciences, University of ChicagoPureMHC LLCMedicinal Chemistry Core, Oregon Health & Science UniversityDepartment of Microbiology, Immunology, and Pathology, Colorado State UniversityDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences CenterDivision of Infectious Diseases, Department of Pediatrics, Oregon Health & Science UniversityDepartment of Biochemistry and Molecular Biology, University of ChicagoDivision of Infectious Diseases, Department of Pediatrics, Oregon Health & Science UniversityVA Portland Health Care SystemAbstract MR1-restricted T (MR1T) cells recognize microbial small molecule metabolites presented on the MHC Class I-like molecule MR1 and have been implicated in early effector responses to microbial infection. As a result, there is considerable interest in identifying chemical properties of metabolite ligands that permit recognition by MR1T cells, for consideration in therapeutic or vaccine applications. Here, we made chemical modifications to known MR1 ligands to evaluate the effect on MR1T cell activation. Specifically, we modified 6,7-dimethyl-8-d-ribityllumazine (DMRL) to generate 6,7-dimethyl-8-d-ribityldeazalumazine (DZ), and then further derivatized DZ to determine the requirements for retaining MR1 surface stabilization and agonistic properties. Interestingly, the IFN-γ response toward DZ varied widely across a panel of T cell receptor (TCR)-diverse MR1T cell clones; while one clone was agnostic toward the modification, most displayed either an enhancement or depletion of IFN-γ production when compared with its response to DMRL. To gain insight into a putative mechanism behind this phenomenon, we used in silico molecular docking techniques for DMRL and its derivatives and performed molecular dynamics simulations of the complexes. In assessing the dynamics of each ligand in the MR1 pocket, we found that DMRL and DZ exhibit differential dynamics of both the ribityl moiety and the aromatic backbone, which may contribute to ligand recognition. Together, our results support an emerging hypothesis for flexibility in MR1:ligand-MR1T TCR interactions and enable further exploration of the relationship between MR1:ligand structures and MR1T cell recognition for downstream applications targeting MR1T cells.https://doi.org/10.1038/s41598-022-26259-y
spellingShingle Haihong Jin
Nicole A. Ladd
Andrew M. Peev
Gwendolyn M. Swarbrick
Meghan Cansler
Megan Null
Christopher T. Boughter
Curtis McMurtrey
Aaron Nilsen
Karen M. Dobos
William H. Hildebrand
Deborah A. Lewinsohn
Erin J. Adams
David M. Lewinsohn
Melanie J. Harriff
Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
Scientific Reports
title Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
title_full Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
title_fullStr Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
title_full_unstemmed Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
title_short Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
title_sort deaza modification of mr1 ligands modulates recognition by mr1 restricted t cells
url https://doi.org/10.1038/s41598-022-26259-y
work_keys_str_mv AT haihongjin deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT nicolealadd deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT andrewmpeev deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT gwendolynmswarbrick deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT meghancansler deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT megannull deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT christophertboughter deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT curtismcmurtrey deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT aaronnilsen deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT karenmdobos deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT williamhhildebrand deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT deborahalewinsohn deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT erinjadams deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT davidmlewinsohn deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells
AT melaniejharriff deazamodificationofmr1ligandsmodulatesrecognitionbymr1restrictedtcells